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Abstract
We report three patients with a predominantly proximal myopathy due to p.A193T mutation in the actin-binding domain of FLNC, which has
so far only been associated with a distal myopathy. They presented with a late onset myopathy characterized by predominant limb-girdle and
proximal weakness. We describe the clinical, electrophysiological, pathological, muscle imaging and genetic features. One of our patients did not
have typical histological features for a myofibrillar myopathy in muscle biopsy. This observation is important for the recognition of the full clinical
spectrum of filamin-C-related myopathies. Muscle imaging has an important role in distinguishing the different filamin-C myopathy types.
© 2016 Published by Elsevier B.V.
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1. Introduction
Filamin-C-related myopathies are autosomal dominant
inherited myopathies caused by mutations in FLNC, the gene
encoding filamin-C. Three distinct types of myopathies have
been described [1–4]. First, pathogenic mutations in the rod
domain of FLNC generally cause a myofibrillar myopathy
(MFM), histologically defined and characterized by focal
disintegration of myofibrils and by formation of large
sarcoplasmic protein aggregates [5]. MFM-filamin-C myopathy
is usually associated with slowly progressive weakness
predominantly affecting proximal muscles and starting in the
fourth-to-sixth decade of life [1,6,7]. The two other filamin-C
myopathy types have been described as distal myopathies with
histological features not fulfilling the criteria required for
diagnosis of MFM. One is caused by a frameshift mutation in
FLNC that leads to a haploinsufficiency [2] and the other by
missense mutations in the actin-binding domain of filamin-C
resulting in increased actin binding affinity [3].
We here describe three patients from two non-related
families with a p.A193T mutation in the actin-binding domain
of FLNC, all presenting with a predominantly proximal
myopathy but with a more variable phenotype than the MFM
subtype. This report thus adds to the clinical spectrum of
filamin-C-related myopathies and can aid in clinical recognition
of this rare disorder.
2. Case report
2.1. Patient 1
A 53-year-old woman presented with mildly elevated serum
creatine kinase levels (301 U/l) and gradually progressive limb
girdle weakness since her forties. Initially, this was considered
to be secondary to hypothyroidism and statin use. However,
supplementation of thyroid hormone and cessation of statin
therapy had not reduced her symptoms. Her walking distance
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was limited to 500 metres, she could not run anymore and
had difficulties climbing stairs. She experienced a feeling of
weakness at the knees, without experiencing falls. She had
kyphoscoliosis since childhood and had never been good at
sports. Her medical history included a short episode of cardiac
arrhythmia which was successfully treated withACE inhibitors.
Her mother, grandmother and great aunt also had slowly
progressive muscle weakness, but without a specific diagnosis.
Physical examination revealed muscle weakness in truncal
muscles, infraspinatus and supraspinatus muscles (MRC 4/5),
neck flexion [4], hip flexion [4] and hip extension [2]. Distal
strength in her arms was normal. Gowers’ sign was present. The
gait was waddling and walking on toes and heels was not
possible. Atrophy was present in distal legs and quadriceps
muscles bilaterally (Fig. 1A). Deep tendon reflexes (DTR) were
absent. Vibration, pain and temperature sense were reduced in
both legs distally.
Electromyography (EMG; at age 48 years) of the anterior
tibial, rectus femoris, biceps brachii, and deltoid muscles
showed no myopathic changes (no small or polyphasic motor
unit action potentials (MUAP)). Muscle biopsy (at age 48
years) from the lateral vastus muscle showed minor
abnormalities: few hypertrophic and some atrophic fibres, and
focal changes that could have been suggestive for fibre type
grouping (Fig. 2A).
Oxidative staining showed some inhomogeneous pattern,
occasionally with some core-like appearance (Fig. 2B), but
electron microscopy (EM) did not exhibit a significant core
A
B
Fig. 1. Proximal and distal muscle atrophy in patient 1 (A) and patient 3 (B).
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pathology (Fig. 2C). Western blot of the muscle was normal
for calpain-3, dysferlin and dystrophin. Cardiac screening
(ultrasound and 24 h-Holter-ECG) showed no abnormalities.
Muscle MRI of lower limbs at the age of 50 years showed
fatty degeneration of several muscles. At the level of the
thighs, the vastus medialis, vastus intermedius, vastus lateralis,
semimembranosus and the long head of the biceps femoris
muscles were affected. The gracilis, sartorius, rectus femoris,
semitendinosus and adductor muscles were relatively spared.
At the lower leg level, the soleus, gastrocnemius medialis,
gastrocnemius lateralis and peroneal group muscles were
involved (Fig. 3A). Nerve conduction studies (NCS; ulnar,
posterior tibial, and common peroneal (motor); radial and sural
nerve (sensory)) at the age of 53 years were normal. A repeated
EMG at the age of 53 years showed mildly myopathic changes
in the gastrocnemius muscle (small, polyphasic MUAP).
Repeated CK was 177 U/l. Proximal myotonic myopathy was
genetically excluded, and no mutations in COL6A1/2/3 (tested
because of the kyphoscoliosis) or RYR1 were detected by
sequencing. Whole exome sequencing (age 53 years) identified
a heterozygous c.577G>A, p.A193T mutation in the actin-
binding domain of FLNC.
2.2. Patient 2
The mother of patient 1 was investigated at the age of 79
years. She had been wearing a corset for scoliosis since the age
of 15 years. Throughout adulthood, she gradually developed
proximal muscle weakness. At the age of 53 years, she was
assessed by a neurologist, who had reported mild muscle
weakness of hip and shoulder girdle. She used a cane or
rollator to walk and became wheelchair dependent in her 60s.
Respiratory weakness with hypoventilation became apparent at
the age of 75 years. Her medical history revealed diabetes,
subclinical hypothyroidism, arterial hypertension and glaucoma.
At age 79 years, muscle weakness was still more pronounced
proximally: shoulder abduction (MRC 2/5), interosseous
muscles [3], finger flexors and extensors [4], iliopsoas muscle
[3], quadriceps muscle [4], gluteal muscles [2] and biceps
femoris [3]. DTR and vibration sense in the legs were reduced.
She died at the age of 82 years due to a respiratory complication
after a leg fracture. The heterozygous c.577G>A, p.A193T
mutation in FLNC, was detected post-mortem.
2.3. Patient 3
This unrelated 58-year-old woman presented with
progressive proximal muscle weakness since the age of 54
years. She stumbled frequently, without falling. The patient had
difficulties walking fast, climbing stairs and rising from a
squatting position or chair. She had exertional dyspnoea and
could not ride a bike for more than 30 minutes. Her parents,
brother and 14-year-old daughter were asymptomatic.
Physical examination showed a waddling gait, and walking
on toes or heels was not possible. Gowers’ sign was present.
Atrophy of the muscles was seen in distal legs and quadriceps
muscles bilaterally (Fig. 1B). Muscle strength in arms and
hands was normal. Both proximal and distal symmetrical
muscle weakness was observed in her legs: iliopsoas and
quadriceps muscle (MRC 3/5); biceps femoris, semitendinosus
and semimembranosus [3], tibialis anterior [2], gastrocnemius
muscle [2], leg adductors and abductors [3]. Temperature sense
was reduced in both feet and vibration sense was reduced to 2/8
on the left and 0/8 on the right malleolus. DTR were decreased
in the upper limbs and absent in the legs.
Fig. 2. Muscle biopsy of patient 1. (A) ATPase (pH 4.2) staining showing
occasionally atrophic fibres (arrows) and focal fibre type clustering, but fibre
type grouping (circled) was not definite. (B) SDH-staining showing some
inhomogeneous distribution pattern, sometimes resembling core-like structures
(arrow). (C) Electron microscopy with the presence of glycogen (*), an uneven
distribution of mitochondria and the absence of myofibrils.
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Fig. 3. Transverse T1-weighted muscle MRI in patient 1 and patient 3. (A) (patient 1): Shoulder and upper arms: no fatty infiltration or atrophy. Hip girdle: mild
fatty infiltration of the gluteus maximus muscle bilaterally. Upper leg: lipomatous alterations of the vastus medialis, intermedius and lateralis, the long head of the
biceps femoris and the semimembranosus. Lower leg: fatty degeneration of the soleus, gastrocnemius medialis, gastrocnemius lateralis and flexor halluces longus
muscles and to a lesser extent of the peroneal group muscles. (B) (patient 3): Shoulder and upper arms: no fatty infiltration or atrophy as far as this could be assessed.
Hip girdle: moderate lipomatous alterations of tensor fascia latae and the iliacus muscles. Upper leg: fatty degeneration of the vastus medialis, intermedius and
lateralis, biceps femoris, semitendinosus and semimembranosus. The adductor magnus is only slightly affected. Lower leg: severe involvement of the gastrocnemius
and soleus muscles.
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Cardiac screening was normal (24 h-Holter-ECG and
echocardiography). Vital capacity was 89% and CK-levels were
normal (106 U/l). EMG showed no myopathic changes in the
anterior tibial, gastrocnemius, and bilateral medial vastus
muscles, and NCS (tibial nerve bilaterally (motor); sural nerve
bilaterally) were normal. Muscle MRI showed a similar
pattern of lower limb muscle involvement as observed in patient
1, but the semitendinosus muscle was more affected (Fig. 3B).
Pompe disease and limb-girdle muscular dystrophy type 2L
(LGMD2L) were excluded by an assessment of enzymatic
activity and Sanger sequencing of the ANO5-gene.
Next-generation sequencing (NGS) panel genetic analysis
revealed the heterozygous c.577G>A, p.A193T mutation in
FLNC.
3. Discussion
We here present three patients from two unrelated families
with the p.A193T mutation in the actin-binding domain of
FLNC associated with a phenotype of predominant limb-girdle
and proximal weakness. The previously reported distal
phenotype associated with mutations in this domain of
filamin-C [3] apparently only represents part of the full
filamin-C myopathy spectrum.
In 2011, two different mutations in the actin-binding domain
of FLNC, p.A193T and p.M251T, have been reported in a
family fromAustralia and Italy, respectively. Affected members
of these families presented with a distal myopathy starting in
the third decade of life in the hands with a characteristic thenar
muscle weakness, followed by posterior calf muscle
involvement in the fourth and proximal weakness in the fifth
decade of life [3]. The clinical phenotype of the three patients
harbouring the p.A193T mutation in this report was clearly
different. Weakness manifested above age 40 years in proximal
lower limbs and involved distal and respiratory muscles later in
the disease course similar as described in the MFM subtype
caused by mutations in the rod domain of FLNC. However,
histological changes in patient 1 were not specific for MFM.
Furthermore, muscle imaging findings in lower legs of patient 3
were typical of filamin-C-related distal myopathy caused by
mutations in the actin-binding domain of filamin-C [3], but also
showed distinct fatty infiltration of thigh muscles. Compared to
the MFM subtype, the vastus lateralis was more affected, while
the adductor magnus, gastrocnemius lateralis and anterior lower
leg muscles were less affected [8,9].
These different and specific patterns of muscle involvement
underline that muscle imaging is useful in the diagnosis of
hereditary myopathies and to distinguish between different
filamin-C related myopathy types. The absence of fatty
replacement in the vastus lateralis sample of patient 1 may be
explained by the fact that muscle biopsy was performed two
years before muscle imaging in this patient.
Interestingly, the p.A193T mutation detected in the patients
in this cohort is identical to the one reported in distal myopathy.
The molecular mechanisms causing myopathy seem to include
an increased actin binding of this filamin C mutant [3]. This
suggests that both phenotypes, distal myopathy and proximal
myopathy, are within the same disease spectrum rather than
allelic disorders. The differences between the two may be due to
yet unknown genetic and environmental causes.
In short, these data indicate that the phenotype of filamin-
C-related myopathy due to mutations in the actin binding
domain is more variable than previously known. Hence,
mutations in FLNC should be considered in patients with
proximal myopathy and late disease onset even if histological
features of MFM are lacking. This observation is important for
scheduling genetic testing in myopathy patients.
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